Biosimilars in Oncology – Part II: Considerations about the clinical use of oncology biosimilars

L Barbier, TB Lacosta, E Moorkens, Y Vandenplas, Arnold Vulto

Research output: Contribution to journalArticleProfessionalpeer-review

Original languageEnglish
Pages (from-to)286-292
JournalBelgian Journal of Medical Oncology
Volume14
Issue number6
Publication statusPublished - 2020

Cite this